SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-090722
Filing Date
2024-08-05
Accepted
2024-08-05 16:05:10
Documents
13
Period of Report
2024-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K enta-20240805.htm   iXBRL 8-K 37521
2 EX-99.1 enta-ex99_1.htm EX-99.1 212297
3 GRAPHIC img152620751_0.jpg GRAPHIC 16316
  Complete submission text file 0000950170-24-090722.txt   398879

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT enta-20240805.xsd EX-101.SCH 25022
15 EXTRACTED XBRL INSTANCE DOCUMENT enta-20240805_htm.xml XML 4757
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35839 | Film No.: 241174704
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)